Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

HIV can cause unusual and severe skin problems that are hard to treat.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Genetic mutations can cause hair growth disorders by affecting key genes and signaling pathways.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The conclusion is that a new biopsy technique and humidity chamber help study skin mites better and suggest mite overpopulation may cause skin diseases.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

The document concludes that terbinafine is effective for treating scalp fungal infections in children and recommends not excluding them from school during treatment, while also highlighting the need for updated treatment guidelines due to changing infection patterns.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

Bariatric surgery affects skin health, causing both direct complications and changes in existing skin conditions, often related to nutritional deficiencies.

Cetuximab can cause eyelash growth, which is rare but manageable.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

A young man was initially misdiagnosed with a scalp condition but was found to have a fungal infection, which improved with antifungal treatment.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.